These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 35469600)
21. The Opioid Crisis: Prevalence and Markets of Opioids. Gardner EA; McGrath SA; Dowling D; Bai D Forensic Sci Rev; 2022 Jan; 34(1):43-70. PubMed ID: 35105535 [TBL] [Abstract][Full Text] [Related]
22. Association between marijuana use and nonmedical prescription opioid use in the United States: are we shifting from one epidemic to another? Arora P; Johnson A; Jayasekare R; Desai K J Public Health Policy; 2021 Jun; 42(2):310-321. PubMed ID: 33879832 [TBL] [Abstract][Full Text] [Related]
23. Medical Marijuana Laws, Marijuana Use, and Opioid-Related Outcomes among Women in the United States. Ali MM; McClellan C; West KD; Mutter R Womens Health Issues; 2021; 31(1):24-30. PubMed ID: 33069561 [TBL] [Abstract][Full Text] [Related]
24. Impact of Marijuana Legalization on Opioid Utilization in Patients Diagnosed with Pain. Neilson LM; Swift C; Swart ECS; Huang Y; Parekh N; Munshi KD; Henderson R; Good CB J Gen Intern Med; 2021 Nov; 36(11):3417-3422. PubMed ID: 33575906 [TBL] [Abstract][Full Text] [Related]
25. Prescription Opioid Distribution after the Legalization of Recreational Marijuana in Colorado. Kropp Lopez AK; Nichols SD; Chung DY; Kaufman DE; McCall KL; Piper BJ Int J Environ Res Public Health; 2020 May; 17(9):. PubMed ID: 32392702 [TBL] [Abstract][Full Text] [Related]
26. Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use. Shah A; Hayes CJ; Lakkad M; Martin BC J Gen Intern Med; 2019 Aug; 34(8):1419-1426. PubMed ID: 30684198 [TBL] [Abstract][Full Text] [Related]
27. Societal Costs and Outcomes of Medical and Recreational Marijuana Policies in the United States: A Systematic Review. French MT; Zukerberg J; Lewandowski TE; Piccolo KB; Mortensen K Med Care Res Rev; 2022 Dec; 79(6):743-771. PubMed ID: 35068253 [TBL] [Abstract][Full Text] [Related]
28. Medical marijuana laws and suicides by gender and age. Anderson DM; Rees DI; Sabia JJ Am J Public Health; 2014 Dec; 104(12):2369-76. PubMed ID: 24432945 [TBL] [Abstract][Full Text] [Related]
29. Association of US Medical Marijuana Laws With Nonmedical Prescription Opioid Use and Prescription Opioid Use Disorder. Segura LE; Mauro CM; Levy NS; Khauli N; Philbin MM; Mauro PM; Martins SS JAMA Netw Open; 2019 Jul; 2(7):e197216. PubMed ID: 31314118 [TBL] [Abstract][Full Text] [Related]
30. Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality. Phillips E; Gazmararian J J Opioid Manag; 2017; 13(4):229-239. PubMed ID: 28953315 [TBL] [Abstract][Full Text] [Related]
31. Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever. Shi Y Drug Alcohol Depend; 2017 Apr; 173():144-150. PubMed ID: 28259087 [TBL] [Abstract][Full Text] [Related]
32. Increasing Rate of Unintentional Firearm Deaths in Youngest Americans: Firearm Prevalence and Covid-19 Pandemic Implication. Bleyer A; Siegel SE; Thomas CR J Natl Med Assoc; 2021 Jun; 113(3):265-277. PubMed ID: 33446333 [TBL] [Abstract][Full Text] [Related]
33. Heterogeneous health effects of medical marijuana legalization: Evidence from young adults in the United States. Chay J; Kim S Health Econ; 2022 Feb; 31(2):269-283. PubMed ID: 34755415 [TBL] [Abstract][Full Text] [Related]
34. Young adult cannabis use disorder treatment admissions declined as past month cannabis use increased in the U.S.: An analysis of states by year, 2008-2017. Mennis J; Stahler GJ; McKeon TP Addict Behav; 2021 Dec; 123():107049. PubMed ID: 34303941 [TBL] [Abstract][Full Text] [Related]
35. Postmortem THC in decedents following legalization of recreational cannabis in Clark County, Nevada. Neiswenter SA; Tupu M; Cross C; Fudenberg J; Harding BE J Forensic Sci; 2022 Jul; 67(4):1632-1639. PubMed ID: 35467020 [TBL] [Abstract][Full Text] [Related]
36. Legalization of marijuana or not? Opinions from over 38,000 residents in Taiwan. Chao KY; Liu SH; Chou CC; Chen CI; Cheng W BMC Public Health; 2023 Oct; 23(1):1954. PubMed ID: 37814243 [TBL] [Abstract][Full Text] [Related]
37. Opioid Death Rate Acceleration in Jurisdictions Legalizing Marijuana Use. Bleyer A; Barnes B JAMA Intern Med; 2018 Sep; 178(9):1280-1281. PubMed ID: 30193245 [No Abstract] [Full Text] [Related]
38. Opioid Death Rate Acceleration in Jurisdictions Legalizing Marijuana Use-Reply. Hockenberry JM; Wen H JAMA Intern Med; 2018 Sep; 178(9):1282. PubMed ID: 30193248 [No Abstract] [Full Text] [Related]
39. Impact of marijuana legalization on cannabis-related visits to the emergency department. Tolan NV; Terebo T; Chai PR; Erickson TB; Hayes BD; Uljon SN; Petrides AK; Demetriou CA; Melanson SEF Clin Toxicol (Phila); 2022 May; 60(5):585-595. PubMed ID: 34935567 [TBL] [Abstract][Full Text] [Related]
40. Association Between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder From 2008 to 2016. Cerdá M; Mauro C; Hamilton A; Levy NS; Santaella-Tenorio J; Hasin D; Wall MM; Keyes KM; Martins SS JAMA Psychiatry; 2020 Feb; 77(2):165-171. PubMed ID: 31722000 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]